Insulet (PODD) Misses Q2 EPS
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $139.21 -2.88%
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cost of revenue: 39.23M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q2 EPS of ($0.37), which may not compare to the analyst estimate of $0.13. Revenue for the quarter came in at $263.2 million versus the consensus estimate of $259.19 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
